Coronavirus: Israel’s Mossad ‘brought’ COVID-19 vaccine from China, says report

Medical workers in protective suits at a coronavirus detection lab in Wuhan in central China's Hubei Province. (File photo: AP)

Israel’s Mossad ‘brought’ a coronavirus vaccine from China to Israel to study it, Israeli media reported on Monday.

Israel’s foreign intelligence brought the vaccine to Israel “in recent weeks in order to study and learn from it,” according to a Jerusalem Post report, citing Israel’s Channel 12.

The report came as Israel announced developments in its domestic coronavirus vaccine development.

Israel’s coronavirus vaccine, research

Israel’s Institute for Biological Research announced Sunday that it will begin human testing for its coronavirus vaccine on November 1 after receiving regulatory approval.

A doctor takes part in a demonstration of ongoing clinical trials led by Sheba Medical Center and Israeli firm Newsight Imaging, in which they say a newly developed saliva test aims to determine in less than a second whether or not you are infected with the coronavirus disease (COVID-19), at Tel Hashomer in Ramat Gan, Israel August 13, 2020. (Reuters)

A doctor takes part in a demonstration of ongoing clinical trials led by Sheba Medical Center and Israeli firm Newsight Imaging, in which they say a newly developed saliva test aims to determine in less than a second whether or not you are infected with the coronavirus disease (COVID-19), at Tel Hashomer in Ramat Gan, Israel August 13, 2020. (Reuters)

Run by Israel’s Defense Ministry, the institute hopes to produce 15 million doses for both Israeli residents and “close neighbors,” director of the institute Dr. Shmuel Shapira told the Associated Press.

Israeli companies announced a partnership with companies in the United Arab Emirates in July to develop research and technology relating to COVID-19.

Two private UAE companies signed a “scientific and medical agreement” with two Israeli companies, state news agency WAM reported at the time.

The UAE is at the end of its Phase III clinical trials of a Chinese COVID-19 vaccine that is expected to be available on the global market by the end of 2020 or early 2021.

The trial is a collaboration between Sinopharm’s China National Biotec Group and Abu Dhabi-based artificial intelligence and cloud computing company Group 42.

A volunteer takes part in the clinical Phase III trial of Sinopharm CNBG’s inactivated vaccine to combat coronavirus in Abu Dhabi, UAE. (Twitter/AShot4Humanity)

A volunteer takes part in the clinical Phase III trial of Sinopharm CNBG’s inactivated vaccine to combat coronavirus in Abu Dhabi, UAE. (Twitter/AShot4Humanity)

Over 40 coronavirus vaccine candidates are in clinical trials worldwide, according to the World Health Organization.

Israel, a country of about 9 million people, has reported over 300,000 cases of COVID-19 and nearly 2,400 deaths

Read more:

After agreeing to normalize ties, Israel to send $5 million of wheat to Sudan

Coronavirus: UAE reports 1,111 COVID-19 cases, significantly lower than recent days

Dubai, Abu Dhabi businesses team up to help Israel firms enter UAE market

SHOW MORE
Last Update: Monday, 26 October 2020 KSA 15:17 - GMT 12:17
Top